These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 23851510)

  • 1. Mechanisms of the androgen receptor splicing in prostate cancer cells.
    Liu LL; Xie N; Sun S; Plymate S; Mostaghel E; Dong X
    Oncogene; 2014 Jun; 33(24):3140-50. PubMed ID: 23851510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.
    Shafi AA; Putluri V; Arnold JM; Tsouko E; Maity S; Roberts JM; Coarfa C; Frigo DE; Putluri N; Sreekumar A; Weigel NL
    Oncotarget; 2015 Oct; 6(31):31997-2012. PubMed ID: 26378018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor and its splice variant, AR-V7, differentially regulate FOXA1 sensitive genes in LNCaP prostate cancer cells.
    Krause WC; Shafi AA; Nakka M; Weigel NL
    Int J Biochem Cell Biol; 2014 Sep; 54():49-59. PubMed ID: 25008967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The splicing modulator sulfonamide indisulam reduces AR-V7 in prostate cancer cells.
    Melnyk JE; Steri V; Nguyen HG; Hann B; Feng FY; Shokat KM
    Bioorg Med Chem; 2020 Oct; 28(20):115712. PubMed ID: 33069070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.
    Fan L; Zhang F; Xu S; Cui X; Hussain A; Fazli L; Gleave M; Dong X; Qi J
    Proc Natl Acad Sci U S A; 2018 May; 115(20):E4584-E4593. PubMed ID: 29712835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancer.
    Yu Z; Chen S; Sowalsky AG; Voznesensky OS; Mostaghel EA; Nelson PS; Cai C; Balk SP
    Clin Cancer Res; 2014 Mar; 20(6):1590-600. PubMed ID: 24449822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-Generation HSP90 Inhibitor Onalespib Blocks mRNA Splicing of Androgen Receptor Variant 7 in Prostate Cancer Cells.
    Ferraldeschi R; Welti J; Powers MV; Yuan W; Smyth T; Seed G; Riisnaes R; Hedayat S; Wang H; Crespo M; Nava Rodrigues D; Figueiredo I; Miranda S; Carreira S; Lyons JF; Sharp S; Plymate SR; Attard G; Wallis N; Workman P; de Bono JS
    Cancer Res; 2016 May; 76(9):2731-42. PubMed ID: 27197266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor.
    Watson PA; Chen YF; Balbas MD; Wongvipat J; Socci ND; Viale A; Kim K; Sawyers CL
    Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16759-65. PubMed ID: 20823238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor splice variant-7 expression emerges with castration resistance in prostate cancer.
    Sharp A; Coleman I; Yuan W; Sprenger C; Dolling D; Rodrigues DN; Russo JW; Figueiredo I; Bertan C; Seed G; Riisnaes R; Uo T; Neeb A; Welti J; Morrissey C; Carreira S; Luo J; Nelson PS; Balk SP; True LD; de Bono JS; Plymate SR
    J Clin Invest; 2019 Jan; 129(1):192-208. PubMed ID: 30334814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression.
    Li Y; Hwang TH; Oseth LA; Hauge A; Vessella RL; Schmechel SC; Hirsch B; Beckman KB; Silverstein KA; Dehm SM
    Oncogene; 2012 Nov; 31(45):4759-67. PubMed ID: 22266865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SF3B2-Mediated RNA Splicing Drives Human Prostate Cancer Progression.
    Kawamura N; Nimura K; Saga K; Ishibashi A; Kitamura K; Nagano H; Yoshikawa Y; Ishida K; Nonomura N; Arisawa M; Luo J; Kaneda Y
    Cancer Res; 2019 Oct; 79(20):5204-5217. PubMed ID: 31431456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-103a-2-5p/miR-30c-1-3p inhibits the progression of prostate cancer resistance to androgen ablation therapy via targeting androgen receptor variant 7.
    Chen W; Yao G; Zhou K
    J Cell Biochem; 2019 Aug; 120(8):14055-14064. PubMed ID: 30963631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor and its splice variant, AR-V7, differentially induce mRNA splicing in prostate cancer cells.
    Rana M; Dong J; Robertson MJ; Basil P; Coarfa C; Weigel NL
    Sci Rep; 2021 Jan; 11(1):1393. PubMed ID: 33446905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of androgen receptor splice variant AR3 by PCGEM1.
    Zhang Z; Zhou N; Huang J; Ho TT; Zhu Z; Qiu Z; Zhou X; Bai C; Wu F; Xu M; Mo YY
    Oncotarget; 2016 Mar; 7(13):15481-91. PubMed ID: 26848868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7.
    Stockley J; Markert E; Zhou Y; Robson CN; Elliott DJ; Lindberg J; Leung HY; Rajan P
    Sci Rep; 2015 Aug; 5():13426. PubMed ID: 26310125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RNA helicase DDX39B and its paralog DDX39A regulate androgen receptor splice variant AR-V7 generation.
    Nakata D; Nakao S; Nakayama K; Araki S; Nakayama Y; Aparicio S; Hara T; Nakanishi A
    Biochem Biophys Res Commun; 2017 Jan; 483(1):271-276. PubMed ID: 28025139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex impacts of PI3K/AKT inhibitors to androgen receptor gene expression in prostate cancer cells.
    Liu L; Dong X
    PLoS One; 2014; 9(10):e108780. PubMed ID: 25360799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vav3 enhances androgen receptor splice variant activity and is critical for castration-resistant prostate cancer growth and survival.
    Peacock SO; Fahrenholtz CD; Burnstein KL
    Mol Endocrinol; 2012 Dec; 26(12):1967-79. PubMed ID: 23023561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth Inhibition by Testosterone in an Androgen Receptor Splice Variant-Driven Prostate Cancer Model.
    Nakata D; Nakayama K; Masaki T; Tanaka A; Kusaka M; Watanabe T
    Prostate; 2016 Dec; 76(16):1536-1545. PubMed ID: 27473672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeic acid phenethyl ester suppresses the expression of androgen receptor variant 7 via inhibition of CDK1 and AKT.
    Kuo YY; Huo C; Li CY; Chuu CP
    Cancer Gene Ther; 2024 Jun; 31(6):807-815. PubMed ID: 38480977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.